The prognostic value of volumetric reduction of the target lesions after induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma

被引:5
|
作者
Xiang, Zhong-zheng [1 ,2 ]
Liu, Fang [1 ,2 ]
Yan, Ruo-nan [1 ,2 ]
Zeng, Yuan-yuan [1 ,2 ]
He, Tao [1 ,2 ]
Zeng, Zhen [1 ,2 ]
Zhu, Zhi-hui [2 ]
Bai, Long [2 ]
Ma, Jia-chun [1 ,2 ]
Liu, Lei [1 ,2 ]
机构
[1] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Dept Head & Neck Oncol,Canc Ctr, 37 Guo Xue Alley, Chengdu, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, Ctr Canc, Dept Radiat Oncol, Chengdu, Sichuan, Peoples R China
关键词
computed tomography localization; induction chemotherapy; nasopharyngeal carcinoma; prognostic prediction; volumetric reduction ratio; PRIMARY TUMOR VOLUME; CONCURRENT CHEMORADIOTHERAPY; RADIATION-THERAPY; STAGING SYSTEMS; HONG-KONG; CANCER; DOCETAXEL; SURVIVAL; EDITION; 7TH;
D O I
10.1002/hed.25620
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background We explored whether the volumetric reduction ratio of target lesion after induction chemotherapy (IC) had any prognostic value in nasopharyngeal carcinoma (NPC). Methods From 2013 to 2016, 72 NPC patients treated with PCF (paclitaxel, cisplatin, 5-fluorouracil) IC followed by cisplatin-based concurrent chemoradiotherapy were analyzed. The volumes of target lesions before and after IC and survival conditions were assessed. Results For all cases, volumetric reduction ratios of the total tumor load >= optimal cutoff values were significantly associated with increased 2-year progression-free survival, locoregional failure-free survival, and distant metastasis-free survival (DMFS) rates, and for cervical lymph nodes, the volumetric reduction ratio >= optimal cutoff value was significant for DMFS (all P < .05). Accordingly, the optimal cutoff values were 24.56% (AUC = 60.5%), 23.91% (AUC = 57.7%), 29.77% (AUC = 75.8%), and 34.17% (AUC = 62.5%), respectively. Conclusion Volumetric reductions of target lesions after IC are independent survival predictors for NPC, especially for those with N2/N3 disease.
引用
收藏
页码:1863 / 1872
页数:10
相关论文
共 50 条
  • [1] The comparison of prognostic value of tumour volumetric regression ratio and RECIST 1.1 criteria after induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma
    Zeng, Yuan-Yuan
    Xiang, Zhong-Zheng
    He, Tao
    Liu, Fang
    Shao, Bian-Fei
    Yan, Ruo-Nan
    Ma, Jia-Chun
    Wang, Xi-Ran
    Liu, Lei
    [J]. ORAL ONCOLOGY, 2020, 111
  • [2] Induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma
    Wen-Fei Li
    Lei Chen
    Ying Sun
    Jun Ma
    [J]. 癌症, 2016, 35 (11) : 567 - 570
  • [3] Induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma
    Li, Wen-Fei
    Chen, Lei
    Sun, Ying
    Ma, Jun
    [J]. CHINESE JOURNAL OF CANCER, 2016, 35 : 94
  • [4] Reduction of Target Volume and the Corresponding Dose for the Tumor Regression Field after Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
    Wang, Lei
    Wu, Zheng
    Xie, Dehuan
    Zeng, Ruifang
    Cheng, Wanqin
    Hu, Jiang
    Huang, Shaomin
    Zhou, Shu
    Zhong, Rui
    Su, Yong
    [J]. CANCER RESEARCH AND TREATMENT, 2019, 51 (02): : 685 - 695
  • [5] The Comparison of Prognostic Value of Volumetric Regression Ratio and RECIST 1.1 Criteria of the Primary Tumor and Metastatic Lymph Nodes after Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
    Zeng, Y. Y.
    Xiang, Z. Z.
    He, T.
    Liu, F.
    Shao, B. F.
    Yan, R. N.
    Ma, J. C.
    Wang, X. R.
    Zeng, L.
    Liu, L.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E833 - E833
  • [6] Is Gemcitabine and Cisplatin induction chemotherapy superior in locoregionally advanced nasopharyngeal carcinoma?
    Zheng, Wei
    Qiu, Sufang
    Huang, Lingling
    Pan, Jianji
    [J]. PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2015, 31 (04) : 781 - 786
  • [7] Induction Chemotherapy Has No Prognostic Value in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma and Chronic Hepatitis B Infection in the IMRT Era
    Zhang, Lu-Lu
    Zhou, Guan-Qun
    Li, Yang-Chan
    Lin, Ai-Hua
    Ma, Jun
    Qi, Zhen-Yu
    Sun, Ying
    [J]. TRANSLATIONAL ONCOLOGY, 2017, 10 (05): : 800 - 805
  • [8] Prognostic Value of Circulating Lipoprotein in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma
    Yao, Ji-Jin
    He, Xiao-Jun
    Lawrence, Wayne R.
    Zhang, Wang-Jian
    Kou, Jia
    Zhang, Fan
    Zhou, Guan-Qun
    Wang, Si-Yang
    Sun, Ying
    [J]. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 48 (01) : 285 - 292
  • [9] Cetuximab in combination with chemoradiation after induction chemotherapy of locoregionally advanced nasopharyngeal carcinoma: preliminary results
    He, Xia
    Xu, Jianhua
    Guo, Wenjie
    Jiang, Xuesong
    Wang, Xue
    Zong, Dan
    [J]. FUTURE ONCOLOGY, 2013, 9 (10) : 1459 - 1467
  • [10] Prognostic Nomogram For Locoregionally Advanced Nasopharyngeal Carcinoma
    Jiang, Yanming
    Qu, Song
    Pan, Xinbin
    Huang, Shiting
    Zhu, Xiaodong
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)